C12N2795/18111 - CPC Classification

Bacteriophages; Details ssRNA Bacteriophages positive-sense Leviviridae

• C12N2795/18121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 3
• C12N2795/18122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 49
• C12N2795/18123 » Virus like particles [VLP] 58
• C12N2795/18131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 2
• C12N2795/18132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 1
• C12N2795/18133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 1
• C12N2795/18134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 17
• C12N2795/18141 » Use of virus, viral particle or viral elements as a vector 4
• C12N2795/18151 » Methods of production or purification of viral material 8
• C12N2795/18161 » Methods of inactivation or attenuation 0
• C12N2795/18171 » Demonstrated in vivo effect 5
• C12N2795/18188 » For redistribution 0

Recent Application in this class: